Skip to main content
. 2020 Oct 12;75:104243. doi: 10.1016/j.jff.2020.104243

Fig. 15.

Fig. 15

The accurate binding interactions of SARS-COV-2 with active compounds from SFJDC. (A) Isorhamnetin, (B) Kaempferol, (C) Polydatin, (D) Quercetin, (E) Taxifolin, and (F) wogonin.